An HCG rapid test checks human chorionic gonadotropin levels in the blood or urine. The test is mostly done during pregnancy and the measurement means whether a woman is pregnant, as well as whether their body is producing the right level of pregnancy hormones.
Increase in the number of childbirth across the globe and demand for advanced tests for better care in order to avoid miscarriages and other health complications are major factors expected to drive the growth of the global HCG rapid test market. According to UN, there are on average about 250 babies born every minute, more than 130 million in a year, and is projected that there will be 11 billion people on earth by 2100. The preventive care approach towards pregnancy in order to avoid gynecological disorders and infertility along with inclination towards adoption of various tests is increasing demand for HCG rapid test. Changing patient diagnostic approach towards homecare testing, rapid advancements in testing kits and introduction of innovative solutions from major players are major factor expected to drive the growth of global HCG rapid test market. Major players are investing high for product development activities with focus on development of product that aid women in conducting test for pregnancy at an early stage, with greater convenience and precision & accuracy. In 2016, NG Biotech a biotechnology company in collaboration with Atomo Diagnostics launched “NG-Test Blood Precision hCG” fully-integrated blood-based rapid test for detection of hCG levels in pregnancy. The developed product has built-in safety lancet, a unique blood collection and delivery system, and an integrated buffer delivery feature, which collectively help to prevent user-related errors and improve test performance. The product launch helped the company to enhance the product portfolio.
Strategic business development activities by major players through innovative product launch and acquisitions are factors responsible to augment the market growth. In 2018, NOW Diagnostics Inc., a medical diagnostic company, received EC Design Examination Certificate, allowing its ADEXUSDx hCG pregnancy test to be sold over-the-counter (OTC) throughout the European Union. This is expected to help the company to enhance the business presence and increase the revenue share. High spending by the government of developing countries on healthcare infrastructure development and favorable business policies in order to strengthen the regional manufacturing capabilities are factors expected to boost the growth of HCG rapid test market. Factors such as stringent government regulations related to product approval and availability of other tests options are expected to hamper the growth of global HCG rapid test market. However, increasing product awareness activities by the government of developing countries, high investment for R&D activities and introduction of innovative solutions are factors expected to create new opportunities for players operating in the HCG rapid test market over the forecast period. In addition, increasing partnership and agreements in order to enhance the business in untapped economies is expected to support the revenue transaction growth of the target market.
Segment Analysis By Region
The market in North America is expected to account for major revenue share in the global HCG rapid test market due to increase in awareness among consumers related to pregnancy tests. Factors such as high spending by the government on R&D activities, presence of large number of players operating in the region, and introduction of innovative solutions are expected to positively impact the growth of target market. In addition, increasing merger and acquisition activities by major players in order to enhance the business presence and increase the customer base is expected to augment the regional market growth.
The market in Asia Pacific is expected to witness faster growth in the target market due to changing government regulations related to patient diagnostic.
In addition, increasing adoption of home based diagnostic testing is increase the demand for pregnancy test kits in the region.
The global HCG rapid test market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition. The players profiled in the report are Church & Dwight, Swiss Precision Diagnostics, Abbott Laboratories, Quidel Corporation, BioMerieux SA, Geratherm Medical AG, China Resources Zizhu Pharmaceutical Co., Ltd., Runbio Biotech, Guangzhou Wondfo, Egens Biotech, and CIGA Healthcare.
HCG Rapid Test Market Segment Analysis, 2019
The global HCG rapid test market is segmented into type and application. The type segment is bifurcated into test strip and digital devices. The digital devices segment is expected to witness faster growth in the HCG rapid test market due to easy availability of advanced infrastructure and high spending on advanced healthcare devices form consumers. The application segment is divided into hospital and clinic and home use. Among the application the hospital segment is expected to account for major revenue share in the target market due to high government spending on the development of hospital infrastructure.
Market By Type
Market By Application
Hospital and Clinic
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Increase in number of child birth cases across the globe and demand for advanced tests for better care in order to avoid miscarriage are major factors expected to drive the growth of global HCG rapid test market.
In application the more hospital and clinic segment is growing at faster pace.
In the global market the Asia Pacific is expected to grow faster.
Some of the players considered in the report scope are Swiss Precision Diagnostics, Abbott Laboratories, Quidel Corporation, BioMerieux SA, Geratherm Medical AG, China Resources Zizhu Pharmaceutical Co., Ltd., Runbio Biotech, Guangzhou Wondfo, Egens Biotech, and CIGA Healthcare.
The North America is expected to account for major revenue share in the global market.
In type the digital devices segment is growing at faster pace.
Factors such as stringent government regulations related to product approval and availability of other tests options are expected to hamper the growth of global HCG rapid test market.